Safety and efficacy of tazarotene foam for the treatment of acne vulgaris

Safety and efficacy of tazarotene foam for the treatment of acne vulgaris

Tazarotene foam is the first topical retinoid foam approved for the treatment of acne vulgaris. To review the safety and efficacy studies of tazarotene foam in the treatment of moderate to severe acne. Five Phase I safety studies in normal controls are reviewed and two Phase III safety and efficacy...

Full description

Saved in:
Bibliographic Details
Published in:Clinical, cosmetic and investigational dermatology Vol. 6; no. default; pp. 123 - 125
Main Authors: Epstein, Erica L, Stein Gold, Linda
Format: Journal Article
Language:English
Published: New Zealand Dove Medical Press Limited 01-01-2013
Taylor & Francis Ltd
Dove Medical Press
Subjects:
Acne
Drug therapy
Medical research
Medicine, Experimental
Retinoids
Review
acne
topical retinoid
foam
tazarotene
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Tazarotene foam is the first topical retinoid foam approved for the treatment of acne vulgaris. To review the safety and efficacy studies of tazarotene foam in the treatment of moderate to severe acne. Five Phase I safety studies in normal controls are reviewed and two Phase III safety and efficacy studies in patients with moderate to severe acne are reviewed. Tazarotene foam, 0.1% was effective in the treatment of moderate to severe acne vulgaris with an acceptable tolerability profile. This treatment provides a cosmetically favorable alternative for topical retinoid therapy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1178-7015
1178-7015
DOI:10.2147/CCID.S34054